Novel Insights into Head and Neck Cancer using
Novel in silico‑designed estradiol analogues are cytotoxic to a
Novel genomic insertion–deletion in MLH1: possible mechanistic
Novel Dyskerin-Mediated Mechanism of p53
Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Research Report To 2022: Grand View Research, Inc.
Novel DNA-binding compounds for cancer therapy
Novel diagnostic biomarkers for prostate cancer
Novel Colon Cancer Tumor Suppressor Gene, Defensin-β1
Novel CHD5, a tumor suppressor gene in neuroblastomas Tumor
Novel cancer-related regulatory targets for the signalling
Novel cancer therapies: treatments driven by tumour biology
Novel approaches to target HER2
Novel anti–B-cell maturation antigen antibody
Novel antibody to carbonic anhydrase XII with
Novel antibodies directed against the human erythropoietin receptor
Novel Anti-Cancer Peptides Comprising Three Amino Acids
Novel Analogue of Colchicine Induces Selective Pro
Novel Amino Acid Based Lipids (DiLA2™) for the Systemic Delivery
Novel Agents for the Treatment and Diagnosis of Various Cancers
Novel Agents and Targets in Managing Patients With Metastatic
